Rapid Micro Biosystems Inc

RPID

3.870USD

+0.190+5.16%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

Rapid Micro Biosystems Inc's Score

Industry at a Glance

Industry Ranking

98 / 205

Overall Ranking

261 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Rapid Micro Biosystems Inc Highlights

StrengthsRisks

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 63.72% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 28.05M.

Undervalued

The company’s latest PE is -3.88, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 23.36M shares, decreasing 7.42% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 978.78K shares of this stock.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

8.000

Target Price

+117.39%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Rapid Micro Biosystems Inc is 5.80, ranking 185 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 7.84M, representing a year-over-year increase of 3.08%, while its net profit experienced a year-over-year increase of 1.61%.

Score

Industry at a Glance

Previous score

5.80

Change

0



Financials

7.18

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.27

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.90

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.58

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Rapid Micro Biosystems Inc is 6.09, ranking 172 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.88, which is -86.66% below the recent high of -0.52 and -20.93% above the recent low of -4.69.

Score

Industry at a Glance

Previous score

6.09

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 98/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Rapid Micro Biosystems Inc is 8.50, ranking 24 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 8.00, with a high of 8.00 and a low of 8.00.

Score

Industry at a Glance

Previous score

8.50

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Rapid Micro Biosystems Inc is 7.53, ranking 34 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.90 and the support level at 2.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.38

Change

0.15

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Rapid Micro Biosystems Inc is 5.00, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 58.78%, representing a quarter-over-quarter decrease of 1.60%. The largest institutional shareholder is The Vanguard, holding a total of 978.78K shares, representing 2.46% of shares outstanding, with 6.94% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Bain Capital Life Sciences Investors, LLC

8.43M

--

Kennedy Lewis Investment Management LLC

4.94M

--

Longitude Capital Management Co., LLC

3.56M

--

Endeavour Medtech Growth II LP

2.26M

--

Ally Bridge Group (HK) Limited

1.85M

--

The Vanguard Group, Inc.

Star Investors

965.02K

+6.71%

Parkman Healthcare Partners LLC

913.44K

--

Schonfeld Strategic Advisors LLC

646.58K

-37.69%

Advent International L.P.

577.78K

--

Spignesi (Robert G JR)

498.32K

+0.89%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Rapid Micro Biosystems Inc is 2.45, ranking 157 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.42. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Rapid Micro Biosystems Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Rapid Micro Biosystems Inc

RPID

6.31 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment